Alerts will be sent to your verified email
Verify Email
TRIMURTHI
|
Novelix Pharma
|
Binny Mills
|
Dipna Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-17.5 % | 2.38 % | 16.1 % |
|
5yr average Equity Multiplier
|
1.26 | -1.02 | 14.87 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 0.04 | 1.35 |
|
5yr Avg Net Profit Margin
|
-14.11 % | -67.35 % | 0.81 % |
|
Price to Book
|
8.06 | 0.0 | 1.43 |
|
P/E
|
102.2 | 0.0 | 56.16 |
|
5yr Avg Cash Conversion Cycle
|
29.1 Days | 15.76 Days | -33.62 Days |
|
Inventory Days
|
34.04 Days | 84.09 Days | 62.45 Days |
|
Days Receivable
|
55.38 Days | 20.05 Days | 112.8 Days |
|
Days Payable
|
55.7 Days | 129.33 Days | 139.84 Days |
|
5yr Average Interest Coverage Ratio
|
-17.77 | 0.6 | 2.01 |
|
5yr Avg ROCE
|
-15.4 % | -152.87 % | 12.33 % |
|
5yr Avg Operating Profit Margin
|
-16.49 % | 5.31 % | 2.41 % |
|
5 yr average Debt to Equity
|
0.05 | -0.82 | 5.84 |
|
5yr CAGR Net Profit
|
35.78 % | n/a | 117.34 % |
|
5yr Average Return on Assets
|
-13.36 % | -3.02 % | 1.21 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.75 % | 68.97 % | 9.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.17 % | -5.89 % | -56.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Novelix Pharma
|
Binny Mills
|
Dipna Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|